Source:http://linkedlifedata.com/resource/pubmed/id/19932761
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-2-4
|
pubmed:abstractText |
Cellular FLICE-inhibitory protein (c-FLIP) is a catalytically inactive procaspase-8/10 homologue that associates with the signalling complex downstream of death-receptors negatively interfering with apoptotic signalling. Three c-FLIP splice variants have been identified: c-FLIP(L), c-FLIP(S) and c-FLIP(R), with all three functioning as apoptosis inhibitors involved in modulation of caspase-8/10 activity in both physiologic and pathologic contexts. Furthermore, a cell-type specific pro-apoptotic role, depending on caspase-8 to c-FLIP(L) ratio, has also been described for the long isoform. The present review summarizes recent findings concerning c-FLIP proteins' function and regulation, with a main focus on the c-FLIP(L) deregulated expression in cancer. The role of c-FLIP(L) as anti-apoptotic pro-survival factor in tumors and the potential utility of this molecule as a possible alternative therapeutic target are discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1878-5875
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
210-3
|
pubmed:meshHeading |
pubmed-meshheading:19932761-Animals,
pubmed-meshheading:19932761-Antineoplastic Agents,
pubmed-meshheading:19932761-Apoptosis,
pubmed-meshheading:19932761-CASP8 and FADD-Like Apoptosis Regulating Protein,
pubmed-meshheading:19932761-Humans,
pubmed-meshheading:19932761-Neoplasms,
pubmed-meshheading:19932761-Signal Transduction
|
pubmed:year |
2010
|
pubmed:articleTitle |
Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer.
|
pubmed:affiliation |
Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, Milan, Italy. marina.bagnoli@istitutotumori.mi.it
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|